Aarti Drugs Limited (AARTIDRUGS.NS)
INR 329.15
(2.09%)
INR 329.15
(2.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.14 Billion INR | 3.21% |
| 2022 | 2.56 Billion INR | -10.96% |
| 2021 | 2.88 Billion INR | -25.7% |
| 2020 | 3.88 Billion INR | 81.86% |
| 2019 | 2.13 Billion INR | 28.52% |
| 2018 | 1.66 Billion INR | 0.34% |
| 2017 | 1.65 Billion INR | 41.82% |
| 2016 | 1.16 Billion INR | 20.25% |
| 2015 | 970.39 Million INR | -3.78% |
| 2014 | 1 Billion INR | 16.38% |
| 2013 | 866.6 Million INR | 31.55% |
| 2012 | 658.78 Million INR | 102.44% |
| 2011 | 325.41 Million INR | -36.09% |
| 2010 | 509.18 Million INR | -23.38% |
| 2009 | 664.56 Million INR | 26.07% |
| 2008 | 527.11 Million INR | 52.43% |
| 2007 | 345.81 Million INR | 11.74% |
| 2006 | 309.48 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 533.2 Million INR | 3.39% |
| 2024 Q1 | 515.7 Million INR | -28.6% |
| 2023 Q3 | 591.5 Million INR | -8.32% |
| 2023 FY | 2.65 Billion INR | 3.21% |
| 2023 Q4 | 722.3 Million INR | 22.11% |
| 2023 Q1 | 720.7 Million INR | -12.01% |
| 2023 Q2 | 645.2 Million INR | -10.48% |
| 2022 FY | 2.56 Billion INR | -10.96% |
| 2022 Q3 | 590.4 Million INR | -4.25% |
| 2022 Q2 | 616.6 Million INR | 12.4% |
| 2022 Q4 | 819.1 Million INR | 38.74% |
| 2022 Q1 | 548.6 Million INR | -25.97% |
| 2021 FY | 2.88 Billion INR | -25.7% |
| 2021 Q1 | 672.8 Million INR | -11.96% |
| 2021 Q2 | 613.3 Million INR | -8.84% |
| 2021 Q3 | 840.6 Million INR | 37.06% |
| 2021 Q4 | 741.07 Million INR | -11.84% |
| 2020 Q2 | 1.03 Billion INR | -14.57% |
| 2020 Q3 | 931.1 Million INR | -10.37% |
| 2020 Q4 | 764.16 Million INR | -17.93% |
| 2020 Q1 | 1.21 Billion INR | 76.87% |
| 2020 FY | 3.88 Billion INR | 81.86% |
| 2019 FY | 2.13 Billion INR | 28.52% |
| 2019 Q4 | 687.47 Million INR | 24.7% |
| 2019 Q3 | 551.3 Million INR | -1.92% |
| 2019 Q2 | 562.1 Million INR | 31.0% |
| 2019 Q1 | 429.1 Million INR | -16.23% |
| 2018 Q2 | 363.7 Million INR | -13.84% |
| 2018 FY | 1.66 Billion INR | 0.34% |
| 2018 Q4 | 512.21 Million INR | 24.54% |
| 2018 Q3 | 411.3 Million INR | 13.09% |
| 2018 Q1 | 422.1 Million INR | -9.01% |
| 2017 Q1 | 167.2 Million INR | -94.91% |
| 2017 Q3 | 350.2 Million INR | 1.39% |
| 2017 Q4 | 463.9 Million INR | 32.47% |
| 2017 FY | 1.65 Billion INR | 41.82% |
| 2017 Q2 | 345.4 Million INR | 106.58% |
| 2016 Q2 | 326.2 Million INR | 14.26% |
| 2016 FY | 1.16 Billion INR | 20.25% |
| 2016 Q3 | 240.9 Million INR | -26.15% |
| 2016 Q4 | 3.28 Billion INR | 1263.47% |
| 2016 Q1 | 285.5 Million INR | -91.57% |
| 2015 Q2 | 227.2 Million INR | -7.45% |
| 2015 Q3 | 227.8 Million INR | 0.26% |
| 2015 FY | 970.39 Million INR | -3.78% |
| 2015 Q4 | 3.38 Billion INR | 1387.53% |
| 2015 Q1 | 245.5 Million INR | -5.04% |
| 2014 Q3 | 268.5 Million INR | 5.25% |
| 2014 Q2 | 255.1 Million INR | 12.78% |
| 2014 Q1 | 226.2 Million INR | -18.81% |
| 2014 FY | 1 Billion INR | 16.38% |
| 2014 Q4 | 258.54 Million INR | -3.71% |
| 2013 Q2 | 204.6 Million INR | 20.14% |
| 2013 Q3 | 212.2 Million INR | 3.71% |
| 2013 Q1 | 170.3 Million INR | 126.99% |
| 2013 FY | 866.6 Million INR | 31.55% |
| 2013 Q4 | 278.6 Million INR | 31.29% |
| 2012 Q4 | -630.98 Million INR | -215.12% |
| 2012 Q1 | 475.4 Million INR | 0.0% |
| 2012 Q3 | 548.1 Million INR | -0.49% |
| 2012 Q2 | 550.8 Million INR | 15.86% |
| 2012 FY | 658.78 Million INR | 102.44% |
| 2011 FY | 325.41 Million INR | -36.09% |
| 2010 FY | 509.18 Million INR | -23.38% |
| 2009 FY | 664.56 Million INR | 26.07% |
| 2008 FY | 527.11 Million INR | 52.43% |
| 2007 FY | 345.81 Million INR | 11.74% |
| 2006 FY | 309.48 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -24.151% |
| Hester Biosciences Limited | 364.77 Million INR | -1859.789% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -128.531% |
| Albert David Limited | 1.33 Billion INR | -435.703% |
| Alembic Limited | 767.77 Million INR | -831.102% |
| Alkem Laboratories Limited | 19.46 Billion INR | 63.268% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -2907.949% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -34508.453% |
| Brooks Laboratories Limited | -72.25 Million INR | 9994.151% |
| Eris Lifesciences Limited | 5.18 Billion INR | -37.96% |
| FDC Limited | 3.03 Billion INR | -135.641% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 20.386% |
| Gufic Biosciences Limited | 2.89 Billion INR | -147.035% |
| Hikal Limited | 1.49 Billion INR | -378.431% |
| Ind-Swift Limited | 1.22 Billion INR | -483.11% |
| Innova Captab Limited | 2.53 Billion INR | -182.178% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -44.647% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -3239.9% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -37.767% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -275.0% |
| Lupin Limited | 27.75 Billion INR | 74.246% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -25935.115% |
| Medico Remedies Limited | 277.11 Million INR | -2479.667% |
| Morepen Laboratories Limited | 4.17 Billion INR | -71.275% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -83.744% |
| Orchid Pharma Limited | 2.36 Billion INR | -202.774% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -156.594% |
| RPG Life Sciences Limited | 2.29 Billion INR | -211.858% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -3336.06% |
| Sigachi Industries Limited | 1.47 Billion INR | -385.022% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 285.541% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -55.149% |
| Themis Medicare Limited | 1.3 Billion INR | -448.591% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -113479.949% |
| Wanbury Limited | 1.7 Billion INR | -318.738% |
| Windlas Biotech Limited | 1.29 Billion INR | -450.372% |
| ZIM Laboratories Limited | 1.09 Billion INR | -551.001% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -255.829% |
| Ipca Laboratories Limited | 29.59 Billion INR | 75.846% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 93.146% |
| Venus Remedies Limited | 534.65 Million INR | -1237.082% |
| Sakar Healthcare Limited | 495.5 Million INR | -1342.711% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 93.159% |
| Divi's Laboratories Limited | 18.31 Billion INR | 60.957% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -59.787% |
| Mankind Pharma Limited | 40.86 Billion INR | 82.508% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | -81.044% |
| Neuland Laboratories Limited | 5.31 Billion INR | -34.423% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 5.21% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -9.94% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 84.251% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -1051.113% |
| Wockhardt Limited | 140 Million INR | -5006.23% |
| Bal Pharma Limited | 214.56 Million INR | -3231.666% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 89.445% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -480.724% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -1196.023% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 1.06% |
| Shilpa Medicare Limited | 3.76 Billion INR | -90.046% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 63.67% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -252431.311% |
| Granules India Limited | 6.52 Billion INR | -9.504% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -2768.082% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 71.783% |
| NATCO Pharma Limited | 25.96 Billion INR | 72.465% |
| Suven Life Sciences Limited | -1.22 Billion INR | 683.178% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -36.796% |
| Indoco Remedies Limited | 1.52 Billion INR | -368.953% |
| Alpa Laboratories Limited | 61.51 Million INR | -11521.104% |
| Lasa Supergenerics Limited | -458 Million INR | 1660.839% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 273.722% |